3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
cyclopia sequence
10
Lung Neoplasms
3
Pain
2
Neoplasms, Plasma Cell
2
Multiple Myeloma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sleepiness
1
Peripheral Nervous System Diseases
1
Parasomnias
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Laryngeal Diseases
1
Hypesthesia
1
Glioma
1
Fatigue
1
Exanthema
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Carcinoma
1
Anxiety Disorders
1
Anorexia
1
Acute Pain
1
Interventions
Sunitinib
64
Nivolumab
42
pembrolizumab
36
Bevacizumab
32
Everolimus
31
Sorafenib
25
pazopanib
23
Axitinib
23
cabozantinib
14
aldesleukin
13
Ipilimumab
13
temsirolimus
11
Interferon alpha-2
11
Cyclophosphamide
10
avelumab
9
Magnetic Resonance Spectroscopy
9
Interleukin-2
9
lenvatinib
8
atezolizumab
8
Radiosurgery
8
Gemcitabine
8
Immunoglobulin G
7
Erlotinib Hydrochloride
7
Disulfides
6
fludarabine phosphate
5
Radiotherapy
5
Fluorodeoxyglucose F18
5
peginterferon alfa-2b
4
Vorinostat
4
Tyrosine Kinase Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Renal Cell
×
Minocycline
×
Clear all
No trials found.